共 232 条
[1]
Ascioglu S(2002)Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus Clin Infect Dis 34 7-245
[2]
Rex JH(1998)Predictors of Adverse Outcome in Cancer Patients with Candidemia Am J Med 104 238-11
[3]
De Pauw B(2003)Current Trends in the Epidemiology of Nosocomial Bloodstream Infections in Patients with Hematological Malignancies and Solid Neoplasms in Hospitals in the United States Clin Infect Dis 36 1103-72
[4]
Bennett JE(1982)Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia Am J Med 72 101-64
[5]
BIlle J(1989)Empiric antifungal therapy in febrile granulocytopenic patients. EORTC International Antimicrobial Therapy Cooperative Group Am J Med 86 668-51
[6]
Crokaert F(1990)Empiric treatment of fungal infections in the neutropenic host. Review of the literature and guidelines for use Arch Intern Med 150 2258-34
[7]
Denning DW(2002)2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer Clin Infect Dis 34 730-1402
[8]
Donnelly JP(2002)Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever N Engl J Med 346 225-20
[9]
Edwards JE(2004)Caspofungin versus Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Persistent Fever and Neutropenia N Engl J Med 351 1391-83
[10]
Erjavec Z(1996)Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicentre, prospective and randomised clinical trial Eur J Cancer 32A 814-4